Protocol digest of a randomized phase III study of pola-R-CHP/high-dose methotrexate/IT vs. pola-R-CHP/IT for newly diagnosed diffuse large B-cell lymphoma with high risk of central nervous system relapse: JCOG2201 (PREMIER)

Yusuke Sano, Kana Miyazaki, Motoko Yamaguchi, Senzo Taguchi, Ryunosuke Machida, Kota Kawabata, Haruhiko Fukuda, Kazuyuki Shimada, Hirokazu Nagai, Wataru Munakata, Dai Maruyama, Unknown

Open source

DOI: 10.1093/jjco/hyaf202
Published: 2025-12-17
Container: Japanese Journal of Clinical Oncology
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jjco/hyaf202,
  title = {Protocol digest of a randomized phase III study of pola-R-CHP/high-dose methotrexate/IT vs. pola-R-CHP/IT for newly diagnosed diffuse large B-cell lymphoma with high risk of central nervous system relapse: JCOG2201 (PREMIER)},
  author = {Yusuke Sano and Kana Miyazaki and Motoko Yamaguchi and Senzo Taguchi and Ryunosuke Machida and Kota Kawabata and Haruhiko Fukuda and Kazuyuki Shimada and Hirokazu Nagai and Wataru Munakata and Dai Maruyama and Unknown},
  year = {2025},
  journal = {Japanese Journal of Clinical Oncology},
  doi = {10.1093/jjco/hyaf202},
  url = {https://doi.org/10.1093/jjco/hyaf202}
}

RIS

TY  - JOUR
TI  - Protocol digest of a randomized phase III study of pola-R-CHP/high-dose methotrexate/IT vs. pola-R-CHP/IT for newly diagnosed diffuse large B-cell lymphoma with high risk of central nervous system relapse: JCOG2201 (PREMIER)
AU  - Yusuke Sano
AU  - Kana Miyazaki
AU  - Motoko Yamaguchi
AU  - Senzo Taguchi
AU  - Ryunosuke Machida
AU  - Kota Kawabata
AU  - Haruhiko Fukuda
AU  - Kazuyuki Shimada
AU  - Hirokazu Nagai
AU  - Wataru Munakata
AU  - Dai Maruyama
AU  - Unknown
PY  - 2025
JO  - Japanese Journal of Clinical Oncology
DO  - 10.1093/jjco/hyaf202
UR  - https://doi.org/10.1093/jjco/hyaf202
ER  -

APA

Sano, Y., Miyazaki, K., Yamaguchi, M., Taguchi, S., Machida, R., Kawabata, K., Fukuda, H., Shimada, K., Nagai, H., Munakata, W., Maruyama, D., & Unknown (2025). Protocol digest of a randomized phase III study of pola-R-CHP/high-dose methotrexate/IT vs. pola-R-CHP/IT for newly diagnosed diffuse large B-cell lymphoma with high risk of central nervous system relapse: JCOG2201 (PREMIER). Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyaf202

Source records

crossref · retrieved 2026-09-27T12:24:51.702Z